Atlas Trials

Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants

Clinical trial NCT02708056 · COMPLETED

Trial details

NCT number
NCT02708056
Sponsor
Baskent University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Brain Cancer
Start date
2015-01-01
Primary completion
2016-02-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.